Senseonics Holdings, Inc.
NASDAQ:SENSMedical - Devices
-$0.09 today
- Market cap
- $533.56M
- Beta
- 0.97
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$1.90
Volume 0.87M
Average 0.71M
SENS EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Senseonics Holdings, Inc.NASDAQ: SENS
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA remains negative
Q1 FY2026 EBITDA was -$30.6M, compared with -$12.45M a year earlier. Trailing-twelve-month EBITDA was -$80.8M.
Context
- EBITDA amounted to 177.7% of revenue in FY2025, down 128.0 pp from a year earlier.
- EBITDA increased in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 6 analysts of -$84.01M (-34.1%) for the fiscal year ending Dec 2026, a slowdown from the +8.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$30.6M-59.1% QoQ
- Last fiscal yearDec 2025
- -$62.65M+8.8% YoY
- LTMMar 2026
- -$80.8M-25.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -145.8% | -193.6% | -47.7 pp |
| 1 year | +8.8% | -34.1% | -42.9 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- (62.65M) USD
- Year-over-year change
- +8.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (62.65M) | +8.8% |
| FY2024 | 2024-12-31 | (68.7M) | -43.1% |
| FY2023 | 2023-12-31 | (48.01M) | -129.7% |
| FY2022 | 2022-12-31 | 161.81M | +156.9% |
| FY2021 | 2021-12-31 | (284.52M) | — |
EBITDA vs competitors
How SENS compares with its peers on the latest reported figures
- SENS's LTM Mar 2026 EBITDA of -$80.8M is the lowest of the 6 companies compared; the peer median is $169M.
- Its year-over-year change of -25.3% is the lowest of 5, against a peer median of +51.2%.
- EBITDA amounts to 198.5% of revenue for SENS, versus a peer median of 21.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.56B | +50.0% | +33.9% | 31.4% | |
| LTM Jun 2026 | $657.4M | +61.4% | +67.2% | 21.5% | |
MMEDMiniMed Group, Inc. Common Stock | LTM Jul 2026 | $169M | — | +73.9% | 5.2% |
| LTM Mar 2026 | -$63.5M | +7.9% | — | 57.6% | |
| LTM Mar 2026 | -$71.9M | +52.3% | — | 7.0% | |
| LTM Mar 2026 | -$80.8M | -25.3% | — | 198.5% | |
| Peer median (excluding SENS) | $169M | +51.2% | +67.2% | 21.5% | |
Competitors are the stored peer set for SENS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.68M | 16.39M | 22.39M | 22.47M | 35.26M |
| Cost of Revenue | 14.49M | 13.66M | 19.3M | 21.94M | 19.49M |
| Gross Profit | (811K) | 2.73M | 3.09M | 533K | 15.76M |
| Gross Margin | -5.9% | 16.6% | 13.8% | 2.4% | 44.7% |
| Research & Development | 27.22M | 39.72M | 48.75M | 41.14M | 31.59M |
| Selling, General & Admin | 29.15M | 31.63M | 29.94M | 34.23M | 52.51M |
| Operating Expenses | 56.37M | 71.35M | 78.69M | 75.38M | 84.1M |
| Depreciation & Amortization | 1.24M | 985K | 1.28M | 1.48M | 1.51M |
| EBITDA | (284.52M) | 161.81M | (48.01M) | (68.7M) | (62.65M) |
| EBITDA Margin | -2080.5% | 987.3% | -214.4% | -305.7% | -177.7% |
| Operating Income | (57.18M) | (68.63M) | (75.6M) | (74.84M) | (68.34M) |
| Operating Margin | -418.1% | -418.7% | -337.7% | -333.0% | -193.8% |
| Interest Income | 243K | 1.82M | 5.36M | 4.5M | 4.2M |
| Interest Expense | 16.72M | 18.7M | 11.11M | 8.44M | 4.95M |
| Other Income / Expenses | (245.29M) | 210.75M | 15.21M | (3.77M) | (776K) |
| Income Before Tax | (302.47M) | 142.12M | (60.39M) | (78.62M) | (69.11M) |
| Pre-Tax Margin | -2211.9% | 867.2% | -269.7% | -349.8% | -196.0% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (302.47M) | 142.12M | (60.39M) | (78.62M) | (69.11M) |
| Net Margin | -2211.9% | 867.2% | -269.7% | -349.8% | -196.0% |
| EPS (Basic) | (14.40) | 6.07 | (2.20) | (2.50) | (1.66) |
| EPS (Diluted) | (14.40) | (2.17) | (2.20) | (2.50) | (1.66) |
| Weighted Avg Shares | 21.12M | 23.4M | 28.4M | 31.49M | 41.73M |
| Weighted Avg Shares (Diluted) | 21.12M | 30.91M | 28.4M | 31.49M | 41.73M |
Senseonics Holdings, Inc.
NASDAQ:SENS
Intrinsic Alpha fair value
Locked
Current Price
$9.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.